U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06973889) titled 'Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients' on May 07.
Brief Summary: 1. Investigating its effectiveness in removing bacteria in invivo conditions
2. Investigating the effectiveness in improving the clinical symptoms of patients
Study Start Date: Dec. 04, 2023
Study Type: INTERVENTIONAL
Condition:
HELICOBACTER PYLORI INFECTIONS
Gastrointestinal Disease
Intervention:
BIOLOGICAL: Helicobacter pylori eradication therapy
12 grams of egg yolk powder containing about 2 grams of antibody twice a day for 2 weeks al...